Veraxa Biotech Holding AG (VRXA) Accounts Payables (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Accounts Payables came in at $1.7 million in Q4 2025, up 212.06% year-on-year from $557682.5 in Q4 2024, and up 212.06% on a QoQ basis from $557682.5 in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Accounts Payables (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Accounts Payables data on file, last reported at $1.7 million in Q4 2025.
- On a quarterly basis, Accounts Payables rose 212.06% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 212.06% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, up 212.06% from the prior year.
- Accounts Payables for Q4 2025 stood at $1.7 million, up from $557682.5 in the prior quarter.
- Over the last five years, Accounts Payables for VRXA reached as high as $1.7 million in Q4 2025 and fell as low as $557682.5 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | 557,682.51 |